Craft
Baxter International

Baxter International

Stock Price

$39

2023-03-07

Market Capitalization

$19.7 B

2023-03-07

Revenue

$15.1 B

FY, 2022

Baxter International Summary

Company summary

Overview
Baxter International is a provider of critical care, nutrition, renal, hospital, and surgical products. The company offers acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and by patients at home under physician supervision.
Type
Public
Status
Active
Founded
1931
HQ
Deerfield, IL, US | view all locations
Website
https://www.baxter.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key people

  • ​​José  E. Almeida

    ​​José E. Almeida, ​Chairman, President and Chief Executive Officer

  • Giuseppe Accogli

    Giuseppe Accogli, Executive Vice President and Chief Operating Officer

  • James Saccaro

    James Saccaro, Executive Vice President and Chief Financial Officer

    • Tobi Karchmer

      Tobi Karchmer, Senior Vice President and Chief Medical Officer

    Operating MetricsView all

    Manufacturing Facilities

    50
    3.8%

    FY, 2020

    Manufacturing Facilities Owned

    36

    FY, 2020

    Manufacturing Facilities Leased

    20
    5.3%

    FY, 2020

    LocationsView all

    69 locations detected

    • Deerfield, IL HQ

      United States

      1 Baxter Pkwy

    • Marion, NC

      United States

      65 Pitts Station Rd

    • Opelika, AL

      United States

      1101 Jeter Ave

    • Round Lake, IL

      United States

      25212 IL-120

    • Wien, Wien

      Austria

      Rund Vier B, Stella-Klein-Löw-Weg 15

    • Braine-l'Alleud, Wallonie

      Belgium

      Boulevard d'Angleterre 2-4

    and 63 others

    Baxter International Financials

    Summary financials

    Revenue (FY, 2022)
    $15.1B
    Gross profit (FY, 2022)
    $5.4B
    Net income (FY, 2022)
    ($2.4B)
    Cash (FY, 2022)
    $1.7B
    EBIT (FY, 2022)
    ($1.9B)
    Enterprise value
    $35.1B

    Blogs

    Footer menu